Amneal Pharmaceuticals (AMRX) Total Debt (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Total Debt of $2.6 billion for Q1 2026, up 17.94% year-over-year from $2.2 billion in Q1 2025, and little changed quarter-over-quarter from $2.6 billion in Q4 2025.
Amneal Pharmaceuticals (AMRX) Total Debt (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Total Debt history runs 10 years deep, the most recent figure standing at $2.6 billion for Q1 2026.
- In Q1 2026, Total Debt rose 17.94% year-over-year to $2.6 billion; the TTM figure through Mar 2026 stood at $2.6 billion (up 17.94% YoY), while the FY2025 annual figure was $2.6 billion, down 1.21% from the prior year.
- Total Debt for Q1 2026 stood at $2.6 billion, roughly flat from $2.6 billion in the prior quarter.
- The five-year high for Total Debt was $2.7 billion in Q1 2022, with the low at $69.2 million in Q3 2022.
- The 5-year median for Total Debt is $2.6 billion (2023), against an average of $2.3 billion.
- The sharpest annual moves came in 2022 and 2025: Total Debt jumped 3934.24% in 2022, then dropped 10.6% in 2025.
- Amneal Pharmaceuticals' Total Debt stood at $2.6 billion in 2022, then declined by 0.87% to $2.6 billion in 2023, then increased by 0.43% to $2.6 billion in 2024, then decreased by 1.21% to $2.6 billion in 2025, then decreased by 0.03% to $2.6 billion in 2026.
- Business Quant data shows AMRX's Total Debt at $2.6 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 2.67 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.67 Bn |
| Mar 31, 2026 | 2.58 Bn |
| Dec 31, 2025 | 2.58 Bn |
| Sep 30, 2025 | 2.58 Bn |
| Jun 30, 2025 | 2.47 Bn |
| Mar 31, 2025 | 2.19 Bn |
| Dec 31, 2024 | 2.61 Bn |
| Sep 30, 2024 | 2.39 Bn |
| Jun 30, 2024 | 2.63 Bn |
| Mar 31, 2024 | 2.45 Bn |
| Dec 31, 2023 | 2.60 Bn |
| Sep 30, 2023 | 2.60 Bn |
| Jun 30, 2023 | 2.58 Bn |
| Mar 31, 2023 | 2.59 Bn |
| Dec 31, 2022 | 2.62 Bn |
| Sep 30, 2022 | 69.22 Mn |
| Jun 30, 2022 | 123.86 Mn |
| Mar 31, 2022 | 2.69 Bn |
| Dec 31, 2021 | 2.68 Bn |
| Sep 30, 2021 | 68.10 Mn |